Bio-Labs is proud to have received the award for “Best Pharmaceutical Corporate – 2024” at the Rawalpindi Chamber of Commerce & Industry – RCCI Annual Members’ Night held at the Jinnah Convention Center, Islamabad on June 13, 2024. The award was presented by the Deputy Prime Minister of Pakistan, Mr. Mohammad Ishaq Dar.
Category: News
Expanding Our Commitment to Women’s Health – New Gynecology Product Line Released
Bio-Labs is thrilled to announce the launch of new gynecology group, featuring a range of promising gynecological medicines dedicated to enhancing women’s health and well-being. This exciting addition testament our commitment to providing safe, effective, and scientifically backed solutions for various gynecological needs. Our sales and marketing teams have worked tirelessly to bring this innovative range to you, ensuring each product meets the highest standards of quality and efficacy.
Among our most valuable products is BIO-MALTOSE, containing ferric carboxymaltose, which is highly recommended as an IV iron supplement to boost hemoglobin levels during pregnancy. Another standout product is OLEN, offering a blend of myo-inositol, D-chiro inositol, and L-methyl folate to alleviate symptoms of polycystic ovary syndrome (PCOS).
With our new group launch, we aim to increase awareness and reach more women who can benefit from our trusted gynecological medicines. Experience the difference and elevate your health with our new range today!
For more details on our full range of gynecology products, please refer to the “LINK“
Voritic (voriconazole) Injection-Another Remarkable Achievement
Bio-Labs Launched Voritic (Voriconazole) IV Injection in its Hi-Tech Portfolio. It is used in treatment of Invasive Fungal Infections (IFI) like invasive aspergillosis, candidaemia, and fluconazole resistant candidiasis in patients who are undergoing transplants, leukemia’s and other critical care settings.
It’s the only true lyophilized formulation available in Pakistan
Launching of Colinext (Colistimethate Sodium) 1MIU
Bio-Labs recently developed Colinext (colistimethate) 1MIU in fulfilling the needs of emerging molecules in the market. It is used in the infections caused by gram negative bacteria’s which are highly resistant to conventional therapies.
